Published in EMBO J on May 01, 2008
Conditional disorder in chaperone action. Trends Biochem Sci (2012) 1.20
Structure, orientation, and dynamics of the C-terminal hexapeptide of LRAP determined using solid-state NMR. J Phys Chem B (2008) 1.06
Increased phospholipase A2 activity with phosphorylation of peroxiredoxin 6 requires a conformational change in the protein. Biochemistry (2012) 0.88
Structural and kinetic mapping of side-chain exposure onto the protein energy landscape. Proc Natl Acad Sci U S A (2011) 0.87
Context-dependent resistance to proteolysis of intrinsically disordered proteins. Protein Sci (2011) 0.84
Ligand binding to a high-energy partially unfolded protein. Protein Sci (2014) 0.77
Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem (1989) 29.15
Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry (1988) 9.18
Intrinsically disordered protein. J Mol Graph Model (2001) 8.54
Mapping the transition state and pathway of protein folding by protein engineering. Nature (1989) 5.44
Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J (2005) 5.36
A perspective on enzyme catalysis. Science (2003) 5.15
Enzyme dynamics during catalysis. Science (2002) 4.39
Natively unfolded proteins. Curr Opin Struct Biol (2005) 4.39
How enzymes work: analysis by modern rate theory and computer simulations. Science (2004) 4.30
Three key residues form a critical contact network in a protein folding transition state. Nature (2001) 3.09
Backbone dynamics in dihydrofolate reductase complexes: role of loop flexibility in the catalytic mechanism. Biochemistry (2001) 2.77
Design and evolution of new catalytic activity with an existing protein scaffold. Science (2006) 2.71
The folding of an enzyme. IV. Structure of an intermediate in the refolding of barnase analysed by a protein engineering procedure. J Mol Biol (1992) 1.84
Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Commun (2001) 1.49
Insights into acylphosphatase structure and catalytic mechanism. Cell Mol Life Sci (1997) 1.32
Determination of an ensemble of structures representing the intermediate state of the bacterial immunity protein Im7. Proc Natl Acad Sci U S A (2005) 1.31
An enzymatic molten globule: efficient coupling of folding and catalysis. Proc Natl Acad Sci U S A (2004) 1.24
Structure and dynamics of a molten globular enzyme. Nat Struct Mol Biol (2007) 1.22
Protein engineering in analysis of protein folding pathways and stability. Methods Enzymol (1991) 1.15
Crystal structure of common type acylphosphatase from bovine testis. Structure (1997) 1.13
Conformational stability of muscle acylphosphatase: the role of temperature, denaturant concentration, and pH. Biochemistry (1998) 1.13
Circularly permuted dihydrofolate reductase possesses all the properties of the molten globule state, but can resume functional tertiary structure by interaction with its ligands. Protein Sci (1996) 1.13
Determination of the folding transition states of barnase by using PhiI-value-restrained simulations validated by double mutant PhiIJ-values. Proc Natl Acad Sci U S A (2005) 1.05
Structure, conformational stability, and enzymatic properties of acylphosphatase from the hyperthermophile Sulfolobus solfataricus. Proteins (2006) 0.99
Structure of a rapidly formed intermediate in ribonuclease T1 folding. Protein Sci (1992) 0.95
Three-dimensional structural characterization of a novel Drosophila melanogaster acylphosphatase. Acta Crystallogr D Biol Crystallogr (2004) 0.94
A new synthesis of benzoyl phosphate: a substrate for acyl phosphatase assay. Experientia (1976) 0.92
Formation of the folding nucleus of an SH3 domain investigated by loosely coupled molecular dynamics simulations. Biophys J (2004) 0.89
Aromatic acyl phosphates as substrates of acyl phosphatase. Arch Biochem Biophys (1966) 0.83
Correlation between evolutionary structural development and protein folding. Proc Natl Acad Sci U S A (2005) 0.83
Development of enzymatic activity during protein folding. Detection of a spectroscopically silent native-like intermediate of muscle acylphosphatase. J Biol Chem (1999) 0.80
NMR solution structure of the acylphosphatase from Escherichia coli. J Biomol NMR (2006) 0.80
Studying the folding process of the acylphosphatase from Sulfolobus solfataricus. A comparative analysis with other proteins from the same superfamily. Biochemistry (2004) 0.78
Crystal structure and structural stability of acylphosphatase from hyperthermophilic archaeon Pyrococcus horikoshii OT3. Proteins (2005) 0.78
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Simultaneous determination of protein structure and dynamics. Nature (2005) 5.28
Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature (2003) 4.98
Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell (2011) 3.98
Protein structure determination from NMR chemical shifts. Proc Natl Acad Sci U S A (2007) 3.96
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol (2005) 3.18
Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc (2005) 3.13
Role of intermolecular forces in defining material properties of protein nanofibrils. Science (2007) 2.94
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR. Nature (2004) 2.84
Prediction of aggregation-prone regions in structured proteins. J Mol Biol (2008) 2.56
Classification of intrinsically disordered regions and proteins. Chem Rev (2014) 2.48
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Kinetic partitioning of protein folding and aggregation. Nat Struct Biol (2002) 2.37
Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol (2007) 2.35
Structure of an intermediate state in protein folding and aggregation. Science (2012) 2.24
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol (2004) 2.14
Relation between native ensembles and experimental structures of proteins. Proc Natl Acad Sci U S A (2006) 2.10
Protein folding: defining a "standard" set of experimental conditions and a preliminary kinetic data set of two-state proteins. Protein Sci (2005) 1.91
Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci (2006) 1.89
Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci (2007) 1.88
Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry (2012) 1.87
Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A (2004) 1.83
The Zyggregator method for predicting protein aggregation propensities. Chem Soc Rev (2008) 1.81
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A (2002) 1.80
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep (2007) 1.78
Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc Natl Acad Sci U S A (2013) 1.75
Fast and accurate predictions of protein NMR chemical shifts from interatomic distances. J Am Chem Soc (2009) 1.75
From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol (2012) 1.71
Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput Biol (2007) 1.71
The MUMO (minimal under-restraining minimal over-restraining) method for the determination of native state ensembles of proteins. J Biomol NMR (2007) 1.65
Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. Structure (2005) 1.63
Nanobodies raised against monomeric α-synuclein distinguish between fibrils at different maturation stages. J Mol Biol (2013) 1.56
A high-throughput approach for measuring temporal changes in the interactome. Nat Methods (2012) 1.55
Insight into the structure of amyloid fibrils from the analysis of globular proteins. PLoS Comput Biol (2006) 1.55
Metastability of native proteins and the phenomenon of amyloid formation. J Am Chem Soc (2011) 1.53
Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J Chem Phys (2011) 1.52
Automated assignment of SCOP and CATH protein structure classifications from FSSP scores. Proteins (2002) 1.48
Determination of a transition state at atomic resolution from protein engineering data. J Mol Biol (2002) 1.47
Protein synthesis rate is the predominant regulator of protein expression during differentiation. Mol Syst Biol (2013) 1.46
A coupled equilibrium shift mechanism in calmodulin-mediated signal transduction. Structure (2008) 1.45
Determination of an ensemble of structures representing the denatured state of the bovine acyl-coenzyme a binding protein. J Am Chem Soc (2004) 1.44
A tensor-free method for the structural and dynamical refinement of proteins using residual dipolar couplings. J Phys Chem B (2014) 1.41
Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem Biol (2012) 1.41
Using NMR chemical shifts as structural restraints in molecular dynamics simulations of proteins. Structure (2010) 1.36
Determination of an ensemble of structures representing the intermediate state of the bacterial immunity protein Im7. Proc Natl Acad Sci U S A (2005) 1.31
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc Natl Acad Sci U S A (2005) 1.31
Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins. Proc Natl Acad Sci U S A (2009) 1.30
Formation of native and non-native interactions in ensembles of denatured ACBP molecules from paramagnetic relaxation enhancement studies. J Mol Biol (2005) 1.27
Calculation of mutational free energy changes in transition states for protein folding. Biophys J (2003) 1.27
The mechanism of folding of Im7 reveals competition between functional and kinetic evolutionary constraints. Nat Struct Mol Biol (2009) 1.26
Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J (2005) 1.25
Blind testing of routine, fully automated determination of protein structures from NMR data. Structure (2012) 1.23
Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. J Chem Phys (2011) 1.23
Mapping of two networks of residues that exhibit structural and dynamical changes upon binding in a PDZ domain protein. J Am Chem Soc (2008) 1.22
Determination of the free energy landscape of alpha-synuclein using spin label nuclear magnetic resonance measurements. J Am Chem Soc (2009) 1.21
ADP ribosylation adapts an ER chaperone response to short-term fluctuations in unfolded protein load. J Cell Biol (2012) 1.20
Characterization of the conformational equilibrium between the two major substates of RNase A using NMR chemical shifts. J Am Chem Soc (2012) 1.20
Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep (2013) 1.20
Toward an accurate determination of free energy landscapes in solution states of proteins. J Am Chem Soc (2009) 1.20
Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol (2005) 1.19
Protein folding and the organization of the protein topology universe. Trends Biochem Sci (2005) 1.19
Characterization of the free-energy landscapes of proteins by NMR-guided metadynamics. Proc Natl Acad Sci U S A (2013) 1.18
Prediction of variable translation rate effects on cotranslational protein folding. Nat Commun (2012) 1.18
Molecular dynamics simulations with replica-averaged structural restraints generate structural ensembles according to the maximum entropy principle. J Chem Phys (2013) 1.17
Molecular determinants of the aggregation behavior of alpha- and beta-synuclein. Protein Sci (2008) 1.17
Inhibition of protein crystallization by evolutionary negative design. Phys Biol (2004) 1.17
Similarities in the thermodynamics and kinetics of aggregation of disease-related Abeta(1-40) peptides. Protein Sci (2007) 1.16
ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Hum Mol Genet (2011) 1.16
Prediction by graph theoretic measures of structural effects in proteins arising from non-synonymous single nucleotide polymorphisms. PLoS Comput Biol (2008) 1.16
Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins. J Mol Biol (2007) 1.16
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol (2008) 1.14
Determination of protein structures consistent with NMR order parameters. J Am Chem Soc (2004) 1.14
BPPred: a Web-based computational tool for predicting biophysical parameters of proteins. Protein Sci (2006) 1.14
Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers. Proc Natl Acad Sci U S A (2012) 1.13
Analysis of the distributed computing approach applied to the folding of a small beta peptide. Proc Natl Acad Sci U S A (2003) 1.13
pE-DB: a database of structural ensembles of intrinsically disordered and of unfolded proteins. Nucleic Acids Res (2013) 1.13
Functional interactions as a survival strategy against abnormal aggregation. FASEB J (2010) 1.13
Crystal structure and anion binding in the prokaryotic hydrogenase maturation factor HypF acylphosphatase-like domain. J Mol Biol (2002) 1.13
Principal eigenvector of contact matrices and hydrophobicity profiles in proteins. Proteins (2005) 1.13
Aggregation of the Acylphosphatase from Sulfolobus solfataricus: the folded and partially unfolded states can both be precursors for amyloid formation. J Biol Chem (2004) 1.11